Nickelodeon Premiers New Show on Kids With Cancer

Now this sounds like a show I want my kids to watch. In two weeks, Nickelodeon will premier "The Face of Courage: Kids Living With Cancer" on Sunday, January 17th at 8pm (ET/PT). Children diagnosed with cancer share their stories on "Nick News With Linda Ellerbee".
The new show explores what life is like for children facing cancer. "All of these kids live as if the cancer were never coming back," says Ellerbee, herself an 18-year cancer survivor. "Cancer is a part of my past. That's a fact. It's a part of my present because I choose to speak about it, and for the same reason, it will be a part of my future. But it is not who I am. It is not who any of us is."
Some of the stories that will be shown include 14-year-old Alexandra who lost her leg to bone cancer. Her cancer is currently in remission and she is learning to use her "bionic" leg. Then there’s Tatyana, who, at 11, made a video to document her treatment for her friends to help them understand what she was going through.

Hector, 14, suffers from a soft tissue cancer that affected an eye socket. “They had to remove my eye or else I was going to die. So they told me to make a choice,” says Hector. Hector worried that losing an eye would make him too different from other kids, but being in a cancer ward gave him a new perspective. “It made me realize that it wasn’t only me. The world was full with kids with cancer.”

Far too many, I’m afraid.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap